Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection

Intraarticular administration of autologous conditioned serum (ACS) recently demonstrated some clinical effectiveness in treatment of osteoarthritis (OA). The current study aims to evaluate the in vitro effects of ACS on cartilage proteoglycan (PG) metabolism, its composition and the effects on syno...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arthritis research & therapy 2010-01, Vol.12 (3), p.R114-R114
Hauptverfasser: Rutgers, Marijn, Saris, Daniël B F, Dhert, Wouter J A, Creemers, Laura B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page R114
container_issue 3
container_start_page R114
container_title Arthritis research & therapy
container_volume 12
creator Rutgers, Marijn
Saris, Daniël B F
Dhert, Wouter J A
Creemers, Laura B
description Intraarticular administration of autologous conditioned serum (ACS) recently demonstrated some clinical effectiveness in treatment of osteoarthritis (OA). The current study aims to evaluate the in vitro effects of ACS on cartilage proteoglycan (PG) metabolism, its composition and the effects on synovial fluid (SF) cytokine levels following intraarticular ACS administration. The effect of conditioned serum on PG metabolism of cultured OA cartilage explants was compared to unconditioned serum. The effect of serum conditioning on levels of interleukin-1beta (IL-1beta), IL-4, IL-6, IL-10, IL-13, interferon gamma (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), osteoprotegerin (OPG), oncostatin M (OSM), interleukin-1 receptor (IL-1ra) and transforming growth factor beta (TGF-beta) were measured by multiplex ELISA. As TNF-alpha levels were found to be increased in conditioned serum, the effect of TNF-alpha inhibition by etanercept on PG metabolism was studied in cartilage explants cultured in the presence of conditioned serum. Furthermore, cytokine levels in SF were measured three days after intraarticular ACS injection in OA patients to verify their retention time in the joint space. PG metabolism was not different in the presence of conditioned serum compared to unconditioned serum. Levels of the anti-inflammatory cytokines IL-1ra, TGF-beta, IL-10 as well as of pro-inflammatory cytokines IL-1beta, IL-6, TNF-alpha and OSM were increased. IL-4, IL-13 and IFN-gamma levels remained similar, while OPG levels decreased. TNF-alpha inhibition did not influence PG metabolism in cartilage explant culture in the presence of conditioned serum. Although OPG levels were higher and TGF-beta levels were clearly lower in ACS than in SF, intraarticular ACS injection in OA patients did not result in significant changes in these cytokine levels. ACS for treatment of osteoarthritis contains increased levels of anti-inflammatory as well as pro-inflammatory cytokines, in particular TNF-alpha, but conditioned serum does not seem to have a net direct effect on cartilage metabolism, even upon inhibition of TNF-alpha. The fast intraarticular clearance of cytokines in the injected ACS may explain the limited effects found previously in vivo.
doi_str_mv 10.1186/ar3050
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2911907</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A230905056</galeid><sourcerecordid>A230905056</sourcerecordid><originalsourceid>FETCH-LOGICAL-b485t-b5361b38ed4511d3890aab1bafd08c9a8fe4d98bf99c166a3eae32e3f41e0abe3</originalsourceid><addsrcrecordid>eNp1ks-KFDEQxhtR3HXVR5CABy_2mnS6ezoXYRn8Bwte9Byq05XZrOnUmKQH9oF8T9PMujig5JDA96uvqvhSVS8FvxRi6N9BlLzjj6pz0W6Gupd98_jh3bVn1bOUbjlvGtW0T6uzhndyI3p-Xv3a3mX64QKyfSTrPDKyDJZMnna0JGYoTC47CjixhHGZmaXIckTIM4a80pQyEsR8EwuY3jIX2MHlSAytRZMTo8BM0Z2HHbIZM4zkXZoZhKnAOUK9qmbxEJnHA_rEwGaMRbwtBqX58-qJBZ_wxf19UX3_-OHb9nN9_fXTl-3VdT22Q5frsZO9GOWAU9sJMclBcYBRjGAnPhgFg8V2UsNolTKi70EioGxQ2lYghxHlRfX-6Ltfxhkng-t0Xu-jmyHeaQKnT5XgbvSODrpRQii-KQbqaDA6-o_BqWJo1sfsSu2b--aRfi6Ysp5dMug9BCxR6I1suRRy0xTy9ZHcgUftgqXiZVZaXzWSq-LW9YW6_AdVzoSzK7niGvdpwau_t3-Y-s9vkb8BFSHHSg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734031372</pqid></control><display><type>article</type><title>Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central</source><source>SpringerNature Complete Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><creator>Rutgers, Marijn ; Saris, Daniël B F ; Dhert, Wouter J A ; Creemers, Laura B</creator><creatorcontrib>Rutgers, Marijn ; Saris, Daniël B F ; Dhert, Wouter J A ; Creemers, Laura B</creatorcontrib><description>Intraarticular administration of autologous conditioned serum (ACS) recently demonstrated some clinical effectiveness in treatment of osteoarthritis (OA). The current study aims to evaluate the in vitro effects of ACS on cartilage proteoglycan (PG) metabolism, its composition and the effects on synovial fluid (SF) cytokine levels following intraarticular ACS administration. The effect of conditioned serum on PG metabolism of cultured OA cartilage explants was compared to unconditioned serum. The effect of serum conditioning on levels of interleukin-1beta (IL-1beta), IL-4, IL-6, IL-10, IL-13, interferon gamma (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), osteoprotegerin (OPG), oncostatin M (OSM), interleukin-1 receptor (IL-1ra) and transforming growth factor beta (TGF-beta) were measured by multiplex ELISA. As TNF-alpha levels were found to be increased in conditioned serum, the effect of TNF-alpha inhibition by etanercept on PG metabolism was studied in cartilage explants cultured in the presence of conditioned serum. Furthermore, cytokine levels in SF were measured three days after intraarticular ACS injection in OA patients to verify their retention time in the joint space. PG metabolism was not different in the presence of conditioned serum compared to unconditioned serum. Levels of the anti-inflammatory cytokines IL-1ra, TGF-beta, IL-10 as well as of pro-inflammatory cytokines IL-1beta, IL-6, TNF-alpha and OSM were increased. IL-4, IL-13 and IFN-gamma levels remained similar, while OPG levels decreased. TNF-alpha inhibition did not influence PG metabolism in cartilage explant culture in the presence of conditioned serum. Although OPG levels were higher and TGF-beta levels were clearly lower in ACS than in SF, intraarticular ACS injection in OA patients did not result in significant changes in these cytokine levels. ACS for treatment of osteoarthritis contains increased levels of anti-inflammatory as well as pro-inflammatory cytokines, in particular TNF-alpha, but conditioned serum does not seem to have a net direct effect on cartilage metabolism, even upon inhibition of TNF-alpha. The fast intraarticular clearance of cytokines in the injected ACS may explain the limited effects found previously in vivo.</description><identifier>ISSN: 1478-6354</identifier><identifier>ISSN: 1478-6362</identifier><identifier>EISSN: 1478-6362</identifier><identifier>DOI: 10.1186/ar3050</identifier><identifier>PMID: 20537160</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Antirheumatic Agents - pharmacology ; Care and treatment ; Cartilage ; Cartilage, Articular - metabolism ; Cells, Cultured ; Culture Media, Conditioned - pharmacology ; Cytokines ; Cytokines - metabolism ; Development and progression ; Etanercept ; Health aspects ; Humans ; Immunoglobulin G - pharmacology ; Injections, Intra-Arterial ; Injections, Intra-articular ; Osteoarthritis ; Osteoarthritis, Knee - drug therapy ; Osteoarthritis, Knee - metabolism ; Patient outcomes ; Physiological aspects ; Proteoglycans - metabolism ; Receptors, Tumor Necrosis Factor ; Synovial fluid ; Synovial Fluid - metabolism ; Tumor Necrosis Factor-alpha - antagonists &amp; inhibitors ; Tumor Necrosis Factor-alpha - metabolism</subject><ispartof>Arthritis research &amp; therapy, 2010-01, Vol.12 (3), p.R114-R114</ispartof><rights>COPYRIGHT 2010 BioMed Central Ltd.</rights><rights>Copyright ©2010 Rutgers et al.; licensee BioMed Central Ltd. 2010 Rutgers et al.; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b485t-b5361b38ed4511d3890aab1bafd08c9a8fe4d98bf99c166a3eae32e3f41e0abe3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911907/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911907/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20537160$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rutgers, Marijn</creatorcontrib><creatorcontrib>Saris, Daniël B F</creatorcontrib><creatorcontrib>Dhert, Wouter J A</creatorcontrib><creatorcontrib>Creemers, Laura B</creatorcontrib><title>Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection</title><title>Arthritis research &amp; therapy</title><addtitle>Arthritis Res Ther</addtitle><description>Intraarticular administration of autologous conditioned serum (ACS) recently demonstrated some clinical effectiveness in treatment of osteoarthritis (OA). The current study aims to evaluate the in vitro effects of ACS on cartilage proteoglycan (PG) metabolism, its composition and the effects on synovial fluid (SF) cytokine levels following intraarticular ACS administration. The effect of conditioned serum on PG metabolism of cultured OA cartilage explants was compared to unconditioned serum. The effect of serum conditioning on levels of interleukin-1beta (IL-1beta), IL-4, IL-6, IL-10, IL-13, interferon gamma (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), osteoprotegerin (OPG), oncostatin M (OSM), interleukin-1 receptor (IL-1ra) and transforming growth factor beta (TGF-beta) were measured by multiplex ELISA. As TNF-alpha levels were found to be increased in conditioned serum, the effect of TNF-alpha inhibition by etanercept on PG metabolism was studied in cartilage explants cultured in the presence of conditioned serum. Furthermore, cytokine levels in SF were measured three days after intraarticular ACS injection in OA patients to verify their retention time in the joint space. PG metabolism was not different in the presence of conditioned serum compared to unconditioned serum. Levels of the anti-inflammatory cytokines IL-1ra, TGF-beta, IL-10 as well as of pro-inflammatory cytokines IL-1beta, IL-6, TNF-alpha and OSM were increased. IL-4, IL-13 and IFN-gamma levels remained similar, while OPG levels decreased. TNF-alpha inhibition did not influence PG metabolism in cartilage explant culture in the presence of conditioned serum. Although OPG levels were higher and TGF-beta levels were clearly lower in ACS than in SF, intraarticular ACS injection in OA patients did not result in significant changes in these cytokine levels. ACS for treatment of osteoarthritis contains increased levels of anti-inflammatory as well as pro-inflammatory cytokines, in particular TNF-alpha, but conditioned serum does not seem to have a net direct effect on cartilage metabolism, even upon inhibition of TNF-alpha. The fast intraarticular clearance of cytokines in the injected ACS may explain the limited effects found previously in vivo.</description><subject>Antirheumatic Agents - pharmacology</subject><subject>Care and treatment</subject><subject>Cartilage</subject><subject>Cartilage, Articular - metabolism</subject><subject>Cells, Cultured</subject><subject>Culture Media, Conditioned - pharmacology</subject><subject>Cytokines</subject><subject>Cytokines - metabolism</subject><subject>Development and progression</subject><subject>Etanercept</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Immunoglobulin G - pharmacology</subject><subject>Injections, Intra-Arterial</subject><subject>Injections, Intra-articular</subject><subject>Osteoarthritis</subject><subject>Osteoarthritis, Knee - drug therapy</subject><subject>Osteoarthritis, Knee - metabolism</subject><subject>Patient outcomes</subject><subject>Physiological aspects</subject><subject>Proteoglycans - metabolism</subject><subject>Receptors, Tumor Necrosis Factor</subject><subject>Synovial fluid</subject><subject>Synovial Fluid - metabolism</subject><subject>Tumor Necrosis Factor-alpha - antagonists &amp; inhibitors</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><issn>1478-6354</issn><issn>1478-6362</issn><issn>1478-6362</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1ks-KFDEQxhtR3HXVR5CABy_2mnS6ezoXYRn8Bwte9Byq05XZrOnUmKQH9oF8T9PMujig5JDA96uvqvhSVS8FvxRi6N9BlLzjj6pz0W6Gupd98_jh3bVn1bOUbjlvGtW0T6uzhndyI3p-Xv3a3mX64QKyfSTrPDKyDJZMnna0JGYoTC47CjixhHGZmaXIckTIM4a80pQyEsR8EwuY3jIX2MHlSAytRZMTo8BM0Z2HHbIZM4zkXZoZhKnAOUK9qmbxEJnHA_rEwGaMRbwtBqX58-qJBZ_wxf19UX3_-OHb9nN9_fXTl-3VdT22Q5frsZO9GOWAU9sJMclBcYBRjGAnPhgFg8V2UsNolTKi70EioGxQ2lYghxHlRfX-6Ltfxhkng-t0Xu-jmyHeaQKnT5XgbvSODrpRQii-KQbqaDA6-o_BqWJo1sfsSu2b--aRfi6Ysp5dMug9BCxR6I1suRRy0xTy9ZHcgUftgqXiZVZaXzWSq-LW9YW6_AdVzoSzK7niGvdpwau_t3-Y-s9vkb8BFSHHSg</recordid><startdate>20100101</startdate><enddate>20100101</enddate><creator>Rutgers, Marijn</creator><creator>Saris, Daniël B F</creator><creator>Dhert, Wouter J A</creator><creator>Creemers, Laura B</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20100101</creationdate><title>Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection</title><author>Rutgers, Marijn ; Saris, Daniël B F ; Dhert, Wouter J A ; Creemers, Laura B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b485t-b5361b38ed4511d3890aab1bafd08c9a8fe4d98bf99c166a3eae32e3f41e0abe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Antirheumatic Agents - pharmacology</topic><topic>Care and treatment</topic><topic>Cartilage</topic><topic>Cartilage, Articular - metabolism</topic><topic>Cells, Cultured</topic><topic>Culture Media, Conditioned - pharmacology</topic><topic>Cytokines</topic><topic>Cytokines - metabolism</topic><topic>Development and progression</topic><topic>Etanercept</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Immunoglobulin G - pharmacology</topic><topic>Injections, Intra-Arterial</topic><topic>Injections, Intra-articular</topic><topic>Osteoarthritis</topic><topic>Osteoarthritis, Knee - drug therapy</topic><topic>Osteoarthritis, Knee - metabolism</topic><topic>Patient outcomes</topic><topic>Physiological aspects</topic><topic>Proteoglycans - metabolism</topic><topic>Receptors, Tumor Necrosis Factor</topic><topic>Synovial fluid</topic><topic>Synovial Fluid - metabolism</topic><topic>Tumor Necrosis Factor-alpha - antagonists &amp; inhibitors</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rutgers, Marijn</creatorcontrib><creatorcontrib>Saris, Daniël B F</creatorcontrib><creatorcontrib>Dhert, Wouter J A</creatorcontrib><creatorcontrib>Creemers, Laura B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Arthritis research &amp; therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rutgers, Marijn</au><au>Saris, Daniël B F</au><au>Dhert, Wouter J A</au><au>Creemers, Laura B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection</atitle><jtitle>Arthritis research &amp; therapy</jtitle><addtitle>Arthritis Res Ther</addtitle><date>2010-01-01</date><risdate>2010</risdate><volume>12</volume><issue>3</issue><spage>R114</spage><epage>R114</epage><pages>R114-R114</pages><issn>1478-6354</issn><issn>1478-6362</issn><eissn>1478-6362</eissn><abstract>Intraarticular administration of autologous conditioned serum (ACS) recently demonstrated some clinical effectiveness in treatment of osteoarthritis (OA). The current study aims to evaluate the in vitro effects of ACS on cartilage proteoglycan (PG) metabolism, its composition and the effects on synovial fluid (SF) cytokine levels following intraarticular ACS administration. The effect of conditioned serum on PG metabolism of cultured OA cartilage explants was compared to unconditioned serum. The effect of serum conditioning on levels of interleukin-1beta (IL-1beta), IL-4, IL-6, IL-10, IL-13, interferon gamma (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), osteoprotegerin (OPG), oncostatin M (OSM), interleukin-1 receptor (IL-1ra) and transforming growth factor beta (TGF-beta) were measured by multiplex ELISA. As TNF-alpha levels were found to be increased in conditioned serum, the effect of TNF-alpha inhibition by etanercept on PG metabolism was studied in cartilage explants cultured in the presence of conditioned serum. Furthermore, cytokine levels in SF were measured three days after intraarticular ACS injection in OA patients to verify their retention time in the joint space. PG metabolism was not different in the presence of conditioned serum compared to unconditioned serum. Levels of the anti-inflammatory cytokines IL-1ra, TGF-beta, IL-10 as well as of pro-inflammatory cytokines IL-1beta, IL-6, TNF-alpha and OSM were increased. IL-4, IL-13 and IFN-gamma levels remained similar, while OPG levels decreased. TNF-alpha inhibition did not influence PG metabolism in cartilage explant culture in the presence of conditioned serum. Although OPG levels were higher and TGF-beta levels were clearly lower in ACS than in SF, intraarticular ACS injection in OA patients did not result in significant changes in these cytokine levels. ACS for treatment of osteoarthritis contains increased levels of anti-inflammatory as well as pro-inflammatory cytokines, in particular TNF-alpha, but conditioned serum does not seem to have a net direct effect on cartilage metabolism, even upon inhibition of TNF-alpha. The fast intraarticular clearance of cytokines in the injected ACS may explain the limited effects found previously in vivo.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>20537160</pmid><doi>10.1186/ar3050</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1478-6354
ispartof Arthritis research & therapy, 2010-01, Vol.12 (3), p.R114-R114
issn 1478-6354
1478-6362
1478-6362
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2911907
source MEDLINE; DOAJ Directory of Open Access Journals; PubMed Central; SpringerNature Complete Journals; PubMed Central Open Access; Springer Nature OA Free Journals
subjects Antirheumatic Agents - pharmacology
Care and treatment
Cartilage
Cartilage, Articular - metabolism
Cells, Cultured
Culture Media, Conditioned - pharmacology
Cytokines
Cytokines - metabolism
Development and progression
Etanercept
Health aspects
Humans
Immunoglobulin G - pharmacology
Injections, Intra-Arterial
Injections, Intra-articular
Osteoarthritis
Osteoarthritis, Knee - drug therapy
Osteoarthritis, Knee - metabolism
Patient outcomes
Physiological aspects
Proteoglycans - metabolism
Receptors, Tumor Necrosis Factor
Synovial fluid
Synovial Fluid - metabolism
Tumor Necrosis Factor-alpha - antagonists & inhibitors
Tumor Necrosis Factor-alpha - metabolism
title Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T09%3A32%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cytokine%20profile%20of%20autologous%20conditioned%20serum%20for%20treatment%20of%20osteoarthritis,%20in%20vitro%20effects%20on%20cartilage%20metabolism%20and%20intra-articular%20levels%20after%20injection&rft.jtitle=Arthritis%20research%20&%20therapy&rft.au=Rutgers,%20Marijn&rft.date=2010-01-01&rft.volume=12&rft.issue=3&rft.spage=R114&rft.epage=R114&rft.pages=R114-R114&rft.issn=1478-6354&rft.eissn=1478-6362&rft_id=info:doi/10.1186/ar3050&rft_dat=%3Cgale_pubme%3EA230905056%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=734031372&rft_id=info:pmid/20537160&rft_galeid=A230905056&rfr_iscdi=true